4//SEC Filing
22NW, LP 4
Accession 0000950170-25-073196
CIK 0001005286other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 11:28 AM ET
Size
12.7 KB
Accession
0000950170-25-073196
Insider Transaction Report
Form 4
22NW Fund, LP
10% Owner
Transactions
- Sale
Common Stock
2025-05-13$7.00/sh−12,334$86,353→ 1,650,240 total(indirect: By: 22NW Fund, LP)
22NW Fund GP, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-05-13$7.00/sh−12,334$86,353→ 1,650,240 total(indirect: By: 22NW Fund, LP)
22NW GP, Inc.
10% Owner
Transactions
- Sale
Common Stock
2025-05-13$7.00/sh−12,334$86,353→ 1,650,240 total(indirect: By: 22NW Fund, LP)
English Aron R.
10% Owner
Transactions
- Sale
Common Stock
2025-05-13$7.00/sh−12,334$86,353→ 1,650,240 total(indirect: By: 22NW Fund, LP)
22NW, LP
10% Owner
Transactions
- Sale
Common Stock
2025-05-13$7.00/sh−12,334$86,353→ 1,650,240 total(indirect: By: 22NW Fund, LP)
Footnotes (3)
- [F1]This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.0100, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.
Documents
Issuer
LIFECORE BIOMEDICAL, INC. \DE\
CIK 0001005286
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001694297
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 11:28 AM ET
- Size
- 12.7 KB